Moreover, overexpression of gC1qR has been associated with poor prognosis in patients with breast cancer [16,17], prostate cancer [18], serous ovarian adenocarcinoma [19], and endometrial cell cancer [20]. This evidence concerns the gene C1QBP and breast cancer.